ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Return 169.78%
This Quarter Return
+1.24%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$119M
AUM Growth
-$35.3M
Cap. Flow
-$20.5M
Cap. Flow %
-17.25%
Top 10 Hldgs %
65.36%
Holding
42
New
8
Increased
12
Reduced
9
Closed
9
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ORIC icon
26
Oric Pharmaceuticals
ORIC
$1.06B
$679K 0.57%
96,000
-7,992
-8% -$56.5K
PLRX icon
27
Pliant Therapeutics
PLRX
$114M
$497K 0.42%
+46,200
New +$497K
RAPP
28
Rapport Therapeutics
RAPP
$524M
$465K 0.39%
+20,000
New +$465K
NAMS icon
29
NewAmsterdam Pharma
NAMS
$3.04B
$432K 0.36%
+22,500
New +$432K
LPTX icon
30
Leap Therapeutics
LPTX
$11.7M
$382K 0.32%
195,000
-159,166
-45% -$312K
CLRB icon
31
Cellectar Biosciences
CLRB
$15.9M
$176K 0.15%
2,350
-2,433
-51% -$182K
NUVB.WS icon
32
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$64.6M
$14.5K 0.01%
90,832
APLT icon
33
Applied Therapeutics
APLT
$68.2M
-792,000
Closed -$5.39M
CLDX icon
34
Celldex Therapeutics
CLDX
$1.52B
-109,000
Closed -$4.57M
HLVX icon
35
HilleVax
HLVX
$105M
-250,609
Closed -$4.17M
IMVT icon
36
Immunovant
IMVT
$2.99B
-92,346
Closed -$2.98M
IRON icon
37
Disc Medicine
IRON
$2.11B
-76,800
Closed -$4.78M
LYRA icon
38
Lyra Therapeutics
LYRA
$11.3M
-3,466
Closed -$1.08M
RARE icon
39
Ultragenyx Pharmaceutical
RARE
$3.07B
-20,000
Closed -$934K
SVRA icon
40
Savara
SVRA
$643M
0
VSTM icon
41
Verastem
VSTM
$663M
-207,095
Closed -$2.44M
ITCI
42
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-13,300
Closed -$920K